Bear Signal Just Flashed for EpiPen Producer

MYL stock rallied Wednesday after an FDA nod

Digital Content Manager
Jan 31, 2019 at 2:44 PM
facebook X logo linkedin


EpiPen producer Mylan NV (NASDAQ:MYL) yesterday rallied more than 7% on Food and Drug Administration (FDA) approval for the company's generic version of Advair. As such, Mizuho this morning raised its price target to $32 from $28. The stock is trading lower today, though -- down 2.8% at $29.96, at last check -- and MYL just flashed a historically bearish signal. 

Specifically, the security just came within one standard deviation of its 60-day moving average, after a lengthy stretch below the trendline. Over the past couple of years, there have been five similar run-ups, according to data from Schaeffer's Senior Quantitative Analyst Rocky White. After these signals, MYL stock averaged a one-month loss of 9.3%, and was lower each time. A similar move from current levels would put the security back at the $27.41 area. 

MYL Chart Jan 31

Mizuho isn't the only analyst waxing optimistic on the stock. Of the 14 analysts following Mylan, seven consider it a "strong buy," and two say "buy." There are only five "hold" ratings and not a single "sell." What's more, the consensus 12-month price target of $41.60 represents a 39.2% premium to current levels. Should the stock extend its long-term descent, a round of downgrades could create even more headwinds. 

Plus, short interest fell 22.06% in the past two reporting periods, to 6.83 million shares, and now only accounts for 1.3% of the stock's available float. This points to little cash on the sidelines to fuel big gains for MYL.

Options traders, on the other hand, have been more bearish than usual. MYL currently sports a 10-day put/call volume ratio of 0.70 on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) that sits in the 81st percentile of its annual range. This suggests that while traders have bought to open more MYL calls than puts on an absolute basis, bearish bets are being initiated at a quicker-than-usual clip.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI